22nd Century
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1998-01-01
- Employees
- 64
- Market Cap
- -
- Website
- http://www.xxiicentury.com
- Introduction
22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco and Hemp/Cannabis segments. The Tobacco segment manufactures branded filtered cigars and cigarettes. The Hemp/Cannabis segment focuses on the bulk ingredient distillate or isolate. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.
Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
A Study to Assess Changes in Cigarette Consumption During a Switch to Very Low Nicotine Cigarettes
- Conditions
- Tobacco Use
- First Posted Date
- 2018-06-28
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- 22nd Century Group, Inc.
- Target Recruit Count
- 142
- Registration Number
- NCT03571724
- Locations
- 🇺🇸
Celerion, Lincoln, Nebraska, United States
🇺🇸High Point Clinical Trials, High Point, North Carolina, United States
Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes
- Conditions
- Tobacco Use
- Interventions
- First Posted Date
- 2018-06-18
- Last Posted Date
- 2020-03-26
- Lead Sponsor
- 22nd Century Group, Inc.
- Target Recruit Count
- 66
- Registration Number
- NCT03559751
- Locations
- 🇺🇸
Vince & Associates Clinical Research, Inc, Overland Park, Kansas, United States
Evaluation of Abuse Liability of Very Low Nicotine (VLN) Mentholated Cigarettes
- Conditions
- Tobacco Use
- Interventions
- First Posted Date
- 2018-06-18
- Last Posted Date
- 2020-03-25
- Lead Sponsor
- 22nd Century Group, Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT03559725
- Locations
- 🇺🇸
Vince and Associates Clinical Research, Inc, Overland Park, Kansas, United States